Cover Image

Generation of two human iPSC lines, HMGUi003-A and MRIi028-A, carrying pathogenic biallelic variants in the PPCS gene

Phosphopantothenoylcysteine synthetase (PPCS) catalyzes the second step of the de novo coenzyme A (CoA) synthesis starting from pantothenate. Mutations in PPCS cause autosomal-recessive dilated cardiomyopathy, often fatal, without apparent neurodegeneration, whereas pathogenic variants in PANK2 and...

Full description

Saved in:
Bibliographic Details
Main Authors: Iuso, Arcangela (Author) , Zhang, Fangfang (Author) , Rusha, Ejona (Author) , Campbell, Birgit (Author) , Dorn, Tatjana (Author) , Zanuttigh, Enrica (Author) , Haas, Dorothea (Author) , Anikster, Yair (Author) , Lederer, Gabriele (Author) , Pertek, Anna (Author) , Nteli, Polyxeni (Author) , Laugwitz, Karl-Ludwig (Author) , Moretti, Alessandra (Author)
Format: Article (Journal)
Language:English
Published: May2022
In: Stem cell research
Year: 2022, Volume: 61, Pages: 1-5
ISSN:1876-7753
DOI:10.1016/j.scr.2022.102773
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1016/j.scr.2022.102773
Verlag, lizenzpflichtig, Volltext: https://www.sciencedirect.com/science/article/pii/S1873506122001222
Get full text
Author Notes:Arcangela Iuso, Fangfang Zhang, Ejona Rusha, Birgit Campbell, Tatjana Dorn, Enrica Zanuttigh, Dorothea Haas, Yair Anikster, Gabriele Lederer, Anna Pertek, Polyxeni Nteli, Karl-Ludwig Laugwitz, Alessandra Moretti
Description
Summary:Phosphopantothenoylcysteine synthetase (PPCS) catalyzes the second step of the de novo coenzyme A (CoA) synthesis starting from pantothenate. Mutations in PPCS cause autosomal-recessive dilated cardiomyopathy, often fatal, without apparent neurodegeneration, whereas pathogenic variants in PANK2 and COASY, two other genes involved in the CoA synthesis, cause Neurodegeneration with Brain Iron Accumulation (NBIA). PPCS-deficiency is a relatively new disease with unclear pathogenesis and no targeted therapy. Here, we report the generation of induced pluripotent stem cells from fibroblasts of two PPCS-deficient patients. These cellular models could represent a platform for pathophysiological studies and testing of therapeutic compounds for PPCS-deficiency.
Item Description:Available online 31 March 2022
Gesehen am 24.06.2022
Physical Description:Online Resource
ISSN:1876-7753
DOI:10.1016/j.scr.2022.102773

Similar Items